UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation

British journal of haematology, 2005-08, Vol.130 (3), p.394-403

2005

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors for life‐threatening bleeding after allogeneic stem cell transplant

British journal of haematology, 2015-06, Vol.169 (5), p.719-725

2015

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Stromal Cells From Myelodysplastic Syndrome Patients Show Lower DICER1 and DROSHA Expression, as Well as Decreased Mir-155 and Mir-181a MicroRNA Expression, When Compared with Healthy Controls

Blood, 2010-11, Vol.116 (21), p.397-397

2010

Link zum Volltext

Verfügbarkeit prüfen

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

Transfusion (Philadelphia, Pa.), 2002-09, Vol.42 (9), p.1159-1172

2002

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndromes

Critical reviews in oncology/hematology, 1996-05, Vol.23 (1), p.57-93

1996

Link zum Volltext

Verfügbarkeit prüfen

1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes

Leukemia research, 1997-04, Vol.21 (1), p.S1-S1

1997

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

Haematologica (Roma), 2011-07, Vol.96 (7), p.1072-1076

2011

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Haematologica (Roma), 2011-03, Vol.96 (3), p.375-383

2011

Link zum Volltext

Verfügbarkeit prüfen

Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology

International journal of laboratory hematology, 2019-02, Vol.41 (1), p.109-117

2019

Link zum Volltext

Verfügbarkeit prüfen

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

Haematologica (Roma), 2012-08, Vol.97 (8), p.1218-1224

2012

Link zum Volltext

Verfügbarkeit prüfen

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes

PloS one, 2016-10, Vol.11 (10), p.e0164370-e0164370

2016

Link zum Volltext

Verfügbarkeit prüfen

Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design

Gaceta sanitaria, 2015-07, Vol.29 (4), p.308-315

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Haematologica (Roma), 2009-07, Vol.94 (7), p.975-983

2009

Link zum Volltext

Verfügbarkeit prüfen

Síndrome de arlequín secundario a neuroblastoma

Anales de pediatría (Barcelona, Spain : 2003), 2019-07, Vol.91 (1), p.60-61

2019

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo identification and characterization of a population of CD13high CD105+ CD45− mesenchymal stem cells in human bone marrow

Stem cell research & therapy, 2015-09, Vol.6 (1), Article 169

2015

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

Stem cell research & therapy, 2015-09, Vol.6, p.169-169

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute graft‐versus‐host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma

Clinical case reports, 2015-06, Vol.3 (6), p.370-375

2015

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation

Haematologica (Roma), 2004-12, Vol.89 (12), p.1421

2004

Link zum Volltext

Verfügbarkeit prüfen

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

Transfusion (Philadelphia, Pa.), 2002-01, Vol.42 (1), p.4-9

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

Leukemia research, 2009-01, Vol.33 (1), p.170-173

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(30)
Hematology
(25)
Female
(23)
Male
(23)
Adult
(20)
Middle Aged
(20)
Aged
(19)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Hematologic And Hematopoietic Diseases
(11)
Adolescent
(10)
Aged, 80 And Over
(7)
Prognosis
(7)
Transplantation, Homologous
(7)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(6)
Myelodysplastic Syndromes - Genetics
(6)
Child
(5)
Multivariate Analysis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation

Incidence and risk factors for life‐threatening bleeding after allogeneic stem cell transplant

Mesenchymal Stromal Cells From Myelodysplastic Syndrome Patients Show Lower DICER1 and DROSHA Expression, as Well as Decreased Mir-155 and Mir-181a MicroRNA Expression, When Compared with Healthy Controls

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients

Myelodysplastic syndromes

1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis

Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Síndrome de arlequín secundario a neuroblastoma

Multivariate time‐dependent comparison of the impact of lenalidomide in lower‐risk myelodysplastic syndromes with chromosome 5q deletion

Ex vivo identification and characterization of a population of CD13high CD105+ CD45− mesenchymal stem cells in human bone marrow

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value

Acute graft‐versus‐host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma

Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

Suchergebnisse filtern